Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TargetFlame
DRKS00029044Phase 3Completed
- Sponsor
- Bezirkskliniken Schwaben
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Celecoxib add-on with Placebo add-on (2 arms). Started Jun 2022; status: completed.
02
Drugs
celecoxib
03
Conditions
schizophrenia
Beyond the preview
Go deeper on DRKS00029044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00029044.